{"brief_title": "Efficacy of \u00c56 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels", "brief_summary": "The purpose of this study is to determine whether injections of \u00c56 are effective in treating ovarian cancer patients who have completed first-line therapy and currently have no detectable cancer but have experienced a doubling of CA 125 levels.", "condition": ["Ovarian Cancer", "Primary Peritoneal Carcinoma"], "intervention_type": ["Drug"], "intervention_name": ["\u00c56 subcutaneous injection"], "criteria": "Inclusion Criteria: - Females \u226518 years of age - Histologically or cytologically documented primary epithelial ovarian carcinoma, cancer of the Fallopian tube, or primary peritoneal carcinoma - Completion of first-line chemotherapy - Clinical remission as a result of chemotherapy - History of normal CA125 level after initial course of therapy - CA125 serum level has shown 2 consecutive rises based on 3 consecutive samples which are mutually >= 28 days apart, provided that: 1. the 3rd sample is above the institution's ULN, and 2. the 3rd sample is confirmed by a 4th sample which is likewise higher than the 2nd sample value and is above the institution's ULN - No clinically evident disease progression, as assessed by history, physical examination, computed tomographic (CT) scan, or magnetic resonance imaging (MRI) - ECOG Performance Status of 0 or 1 - No clinically significantly abnormal clinical laboratory tests or concomitant illnesses - Ability and willingness to self-administer subcutaneous injections - Although pregnancy is extremely unlikely in this patient population because of the disease and prior treatment, patients who have the potential to become pregnant must have a negative pregnancy test and must agree to practice an effective method of contraception throughout the trial. Exclusion Criteria: - Persistent adverse events due to agents administered more than 4 weeks earlier - More than 1 course of previous chemotherapy for the qualifying cancer - Disease requiring chemotherapy or radiotherapy - Ascites - Recent history of active infection, gastrointestinal bleeding, thromboembolic disorders, or anticoagulation", "gender": "Female", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "ovarian cancer", "mesh_term": ["Ovarian Neoplasms"], "id": "NCT00083928"}